Reports for HYDROCHLOROTHIAZIDE
Ingredient
HYDROCHLOROTHIAZIDE
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-QUINAPRIL/HCTZ | 25MG 20MG | TABLET | Resolved | 2018-11-30 | 2019-03-16 | 68245 |
APO-QUINAPRIL/HCTZ | 25MG 20MG | TABLET | Resolved | 2019-07-12 | 2019-11-25 | 89167 |
APO-QUINAPRIL/HCTZ | 25MG 20MG | TABLET | Resolved | 2019-08-21 | 2019-09-16 | 92032 |
APO-QUINAPRIL/HCTZ | 25MG 20MG | TABLET | Resolved | 2020-03-27 | 2020-09-09 | 109686 |
APO-QUINAPRIL/HCTZ | 20MG 25MG | TABLET | Resolved | 2020-04-13 | 2020-09-01 | 111954 |
APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Resolved | 2017-11-07 | 2018-02-26 | 28539 |
APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Resolved | 2017-12-14 | 2018-02-26 | 32772 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TELMISARTAN-HCTZ | 25MG 80MG | TABLET | Discontinued | 2017-10-12 | 2017-10-17 | 25720 |
TELMISARTAN-HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2017-10-12 | 2017-10-17 | 25724 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40823 |
APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40826 |
APO-TELMISARTAN/HCTZ | 25MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-05-07 | 40829 |